‘It’s Going To Be Very Disturbing’: Fauci Says COVID Cases Could Surge By 100,000 A Day
In his Tuesday testimony before members of Congress, infectious disease expert Dr. Anthony Fauci spoke about his concerns over certain states’ reopening plans and the surge of cases the nation has seen in past days. He noted the death totals will be concerning and the country is “going in the wrong direction.”
Before the Senate Health, Education, Labor and Pensions committee, Fauci fielded questions from senators — one question covered new data showing a 40,000 increase in cases one day last week. He said that “we’re not in control” and it would come at no surprise to him if the nation saw an increase by 100,000 cases in one day.
“The numbers speak for themselves,” Fauci testified. “I’m very concerned. I’m not satisfied with what’s going on because we’re going in the wrong direction.”
According to the Guardian, Fauci called out younger Americans to follow guidelines.
“What we saw were a lot of people who maybe felt because they think they are invulnerable – and we know many young people are not because they’re getting serious disease – that therefore their getting infected has nothing to do with anyone else,” Fauci said.
Fauci urged the public to follow CDC and local guidelines, including the wearing of a mask in public and maintaining six feet distance from others.
You may like
FDA will work with China to import cancer drugs due to U.S. shortages
Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.
Foreign Desk News writes:
Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.
“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.
Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.
“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.
The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4
— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023
Foreign Desk News adds:
The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.
You may like
Economy4 days ago
New York City Mayor Eric Adams Proposes Housing Asylum Seekers in Private Homes
Economy5 days ago
Texas Gov Abbott aims to eliminate property taxes: ‘we must dream big’
Immigration4 days ago
Biden Administration to allow 40,000 asylum-seekers per month into US with mobile app
International4 days ago
Saudi Arabia-Israel Deal Remains Biden’s Win to Lose